Mucoepidermoid breast carcinoma

Summary

Mucoepidermoid breast carcinoma (MONDO:0003087) is a cancer. A subtype of mucoepidermoid carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mucoepidermoid breast carcinoma
Mondo ID	MONDO:0003087
DOID	DOID:4679
NCIT	C5166
UMLS	C1334813
MedGen	233721
GARD	0023361
Anatomy (UBERON)	UBERON:0000310
Is cancer (heuristic)	yes

Also known as: breast mucoepidermoid carcinoma · mucoepidermoid breast carcinoma · mucoepidermoid carcinoma of breast · mucoepidermoid carcinoma of the breast

Disease family

This is a subtype of mucoepidermoid carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › mucinous adenocarcinoma › mucoepidermoid carcinoma › mucoepidermoid breast carcinoma

Related subtypes (11): trachea mucoepidermoid carcinoma, thymic mucoepidermoid carcinoma, extrahepatic bile duct mucoepidermoid carcinoma, cutaneous mucoepidermoid carcinoma, lacrimal gland mucoepidermoid carcinoma, mucoepidermoid esophageal carcinoma, laryngeal mucoepidermoid carcinoma, pulmonary mucoepidermoid carcinoma, thyroid gland mucoepidermoid carcinoma, paranasal sinus mucoepidermoid carcinoma, oral cavity mucoepidermoid carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.